We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Evangeline Gonzalez Joins Ubiquitome Board of Directors

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Evangeline Gonzalez Joins Ubiquitome Board of Directors"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Ubiquitome Limited, announced at the Molecular Medicine Triconference in San Francisco, that Evangeline Gonzalez, has joined its Board of Directors.  Ubiquitome’s Freedom4 is the first commercially available handheld, mobile device to offer gold standard real-time PCR performance wherever it is needed.  The company recently established a partnership with Integrated DNA Technologies (IDT) to develop the Ubiquitome Freedom4 real-time RT-PCR Ebola Virus Assay.  

Paul Pickering, Ubiquitome CEO, said “Evangeline has proven expertise in market and product development from leading international biotechnology companies.  Her insight and commercialization experience will be a huge asset to our team as we continue to establish Freedom4 in the marketplace.”

Gonzalez is currently the Senior Vice President of Marketing at Beckman Coulter, a Danaher company, responsible for facilitating growth and marketing strategy for the Diagnostics Division. She began her career at Pharmacia Biotech as a research associate developing products for protein separation. She has worked in R&D, Product Marketing and Strategic Market & Business Development, holding various assignments of increasing responsibility at Genentech, Life Technologies and Advanced Cell Diagnostics. Gonzalez has a BA in chemistry, BS in biochemistry and an MBA in marketing/entrepreneurship from San Francisco State University.

“I’m delighted to join Ubiquitome’s board and be integrally involved in the key strategies and decisions that will help advance broad utilization of the Freedom4,” said Gonzalez.  “The device is positioned to gain strong traction in channels where no other of its kind exists.”  

Fitting in the palm of a hand, Ubiquitome’s Freedom4 instrument operates on battery power alone for up to six hours and delivers gold-standard real-time PCR performance wherever needed. The platform runs using an iPhone or laptop computer, is housed in a rugged aluminum casing and features a solid state design that includes laser-based optical detection, which is widely recognized as offering the highest performance in real-time PCR.